Clinical Trials Logo

Diabetic Neuropathy clinical trials

View clinical trials related to Diabetic Neuropathy.

Filter by:

NCT ID: NCT06452914 Not yet recruiting - Diabetic Neuropathy Clinical Trials

Clinical Outcomes Related to Treatment of Distal Symmetric Polyneuropathy Using Semiconductor Embedded Therapeutic Socks

Start date: June 2024
Phase: N/A
Study type: Interventional

Distal symmetric polyneuropathy, also known as diabetic neuropathy, is the most common neurological complication of diabetes and a main cause of morbidity. The condition leads to gradual loss of function of the longest nerve fibers that limits function and decreases quality of life. Symptoms present distally and symmetrically in toes and feet. Symptoms of the neurologic disability include sensory loss, risk of foot ulcers and limb amputations and pain. The condition is not generally considered reversible, and condition management aims to slow progression and prevent complications. According to estimates from the International Diabetes Federation, diabetic neuropathy affected approximately 425 million people in 2017, with projections indicating a rise to 628 million by 2045. Despite the high prevalence of this condition, it is commonly misdiagnosed and has limited treatment options. There are multiple phenotypes of diabetic neuropathy, with the most common form being distal symmetric sensorimotor polyneuropathy, which is what we will be focusing on in this study. The proposed study seeks to evaluate the effectiveness of a non-compressive therapeutic socks throughout a 12-week course of rehabilitation for managing distal symmetric polyneuropathy. Outcome measures will be collected at standard intervals and compared with pre-treatment measures to evaluate effectiveness of treatment.

NCT ID: NCT05573685 Completed - Clinical trials for Rheumatoid Arthritis

Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training

Start date: October 10, 2022
Phase: N/A
Study type: Interventional

CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a multimodal treatment in supplementary or standalone prescription or nonprescription software-based digital therapeutics (PDT/DTx), being developed by Click Therapeutics, Inc. (Click).

NCT ID: NCT05250999 Completed - Diabetic Neuropathy Clinical Trials

Skin Stretch Sensory Stimuli and TENS in Diabetic Neuropathy

Start date: July 15, 2021
Phase: N/A
Study type: Interventional

The aim of the research was to find and compare the effects of skin stretch sensory stimuli and transcutaneous electrical nerve stimulation (TENS) on balance in diabetic neuropathy. Randomized controlled trial done at District Headquarter hospital Okara. The sample size was 46. The subjects were divided into 3 groups, 15 subjects in skin stretch sensory stimuli group, 15 subjects in TENS group and 16 subjects in control group. Study duration was of 6 month. Sampling technique applied was convenient non-probability sampling. Patients aged range from 45 to 80 years, having moderate peripheral neuropathy, and decrease sensations were included. Tools used in this study were Berg Balance scale and Toronto clinical neuropathy score system. Data was being analyzed through Spss 21.

NCT ID: NCT05243589 Completed - Diabetic Neuropathy Clinical Trials

Effects of Proprioceptive Training in Addition to Routine Physical Therapy on Balance and Quality of Life in Patients With Diabetic Peripheral Neuropathy

Start date: February 26, 2021
Phase: N/A
Study type: Interventional

Objective of the study is to find out the effects of Proprioceptive training in addition to routine physical therapy on balance and quality of life in patients with Diabetic neuropathy. Alternate Hypothesis: There will be significant difference in effects of Proprioceptive training in addition to routine physical therapy on balance and Quality of life in patients with Diabetic neuropathy.

NCT ID: NCT04238208 Completed - Diabetic Neuropathy Clinical Trials

The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy

Start date: January 10, 2019
Phase: Phase 4
Study type: Interventional

The study aims to compare the effectiveness and tolerability of using lidocaine 5% patch to 8% capsaicin patch in patients with diabetic neuropathy. Assessment of analgesic effectiveness was assessed by observing any change in the Numeric Pain Rating Scale (NPRS) score, average daily pain Brief Pain Inventory (BPI) for painful diabetic peripheral neuropathy (BPI-DPN Q4) and Patient Global Impression of Change (PGIC). Assessment of capsaicin and lidocaine safety and identifying treatment adverse effects were secondary endpoints in this study

NCT ID: NCT04082000 Terminated - Diabetic Neuropathy Clinical Trials

Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

Start date: April 15, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

NCT ID: NCT04025320 Completed - Diabetic Neuropathy Clinical Trials

The Effect of Intraneural Facilitation Therapy on Diabetic Patients With Peripheral Neuropathy

Start date: September 27, 2019
Phase: N/A
Study type: Interventional

The purpose of this graduate student research study is to explore the effects of a new treatment known as Intraneural facilitation (INF) on Diabetes Mellitus Type 2 (DMT2) subjects who have moderate - severe below ankle neuropathy symptoms. Since INF has shown success in the clinic and significant improvements have been found in a recent pilot study, this study aims to further explore these effects on DMT2 subjects suffering from DPN. The investigators would like to investigate if INF improves blood flow in the foot, if it decreases the pain and improves the sensation, and if it improves the overall quality of life.

NCT ID: NCT03914404 Completed - Diabetic Neuropathy Clinical Trials

Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic Neuropathy

Start date: January 26, 2016
Phase: Phase 4
Study type: Interventional

This study was a 12-week, multi-center, randomized, double-blind, double dummy, parallel clinical trial to compare the efficacy of γ-linolenic acid and Thioctic acid in patients with diabetic neuropathy.

NCT ID: NCT03755960 Completed - Diabetic Neuropathy Clinical Trials

ACUpuncture in Diabetic Peripheral Neuropathy

ACUDPN
Start date: March 2, 2019
Phase: N/A
Study type: Interventional

Multicentric,randomized, two-armed confirmatory trial on the effectiveness of acupuncture in patients with symptomatic peripheral diabetic neuropathy compared to routine care.

NCT ID: NCT02989831 Completed - Diabetic Neuropathy Clinical Trials

The Effect of Random Vibrations on Perception and Balance

Start date: April 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of vibrating insoles on vibration perception threshold (VPT) and balance of people with diabetic neuropathy.